Regeneron Pharmaceuticals REGN Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's change in AR?
- Regeneron Pharmaceuticals (REGN) reported change in AR of -$1.2M in Q1 2026.
- How has Regeneron Pharmaceuticals's change in AR changed year-over-year?
- Regeneron Pharmaceuticals's change in AR increased by 99.8% year-over-year, from -$657.8M to -$1.2M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.